Gujarat Themis Biosyn LTD

Gujarat Themis Biosyn Ltd (GUJTHEM) is a micro-cap Healthcare company valued at ₹4,069 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Gujarat Themis Biosyn Ltd last traded at ₹372, modestly up 0.53% on the day.

Recent developments

On 2026-09-18, Gujarat Themis Biosyn Limited announced an acquisition, including an agreement to acquire, which may expand its operations or product portfolio.

Financial performance

The company's annual revenue rose 9.8% to ₹166 crore, while annual net profit fell 4.7% to ₹47 crore. In the latest quarter, revenue and net profit both increased by 21.6% and 23.0% respectively compared to the same quarter a year earlier, but the net profit margin narrowed 4.3 percentage points to 28.2%.

Valuation multiples

The stock trades at 86.9 times earnings, a premium to the Healthcare median of 32.0, 7.40 times book value. It yields 0.2%.

Things to watch

The stock is 20.3% below its 52-week high, and net profit margin has declined 4.3 percentage points to 28.2%. Profit growth has slowed, with a 7.0% annual decline in the past three years despite revenue growth of 12.8% over five years.

Where it stands

The company has seen revenue growth of 9.8% annually and a 21.6% rise in the latest quarter, but net profit has declined 4.7% year-on-year. The most significant movement is the 20.3% drop from the 52-week high, reflecting recent underperformance.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.